Literature DB >> 27000083

Morning cortisol levels and glucose metabolism parameters in moderate and severe obstructive sleep apnea patients.

Josko Bozic1, Tea Galic2, Daniela Supe-Domic3, Natalija Ivkovic4, Tina Ticinovic Kurir1, Zoran Valic5, Josip Lesko6, Zoran Dogas7,8.   

Abstract

Obstructive sleep apnea (OSA) has been associated with dysregulation of the hypothalamic-pituitary-adrenal axis and alterations in glucose metabolism with increased risk for type 2 diabetes. The aim of the current study was to compare morning plasma cortisol levels and glucose metabolism parameters between moderate (apnea-hypopnea index (AHI): 15-30 events/h) and severe OSA patients (AHI >30 events/h), with respective controls. A total of 56 male OSA patients, 24 moderate (AHI = 21.1 ± 5.3) and 32 severe (AHI = 49.7 ± 18.1), underwent a full-night polysomnography, oral glucose tolerance test (OGTT), and measurement of morning plasma cortisol levels. These groups were compared to 20 matched subjects in a control group. Morning plasma cortisol levels were statistically lower in severe OSA group than in moderate OSA and control groups (303.7 ± 93.5 vs. 423.9 ± 145.1 vs. 417.5 ± 99.8 pmol/L, P < 0.001). Significant negative correlations were found between morning plasma cortisol levels and AHI (r = -0.444, P = 0.002), as well as oxygen desaturation index (r = -0.381, P = 0.011). Fasting plasma glucose (5.0 ± 0.5 vs. 5.4 ± 0.7 vs. 4.9 ± 0.6 mmol/L, P = 0.009) was higher in the severe OSA group compared to moderate OSA and controls. Homeostasis model assessment insulin resistance (HOMA-IR) was higher in the severe OSA group compared to moderate OSA and controls (4.6 ± 3.7 vs. 2.7 ± 2.0 and 2.2 ± 1.8, respectively, P = 0.006). In conclusion, our study showed that morning plasma cortisol levels measured at 8 a.m. were significantly lower in severe OSA patients than those in moderate OSA group and controls. Morning plasma cortisol levels showed a negative correlation with AHI and oxygen desaturation index. Additionally, this study confirmed the evidence of glucose metabolism impairment in moderate and severe OSA patients, with more pronounced effect in the severe OSA patients group.

Entities:  

Keywords:  Glucose metabolism; Insulin resistance; Morning plasma cortisol levels; Obstructive sleep apnea; Pre-diabetes

Mesh:

Substances:

Year:  2016        PMID: 27000083     DOI: 10.1007/s12020-016-0925-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  43 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

3.  The stress hormone system in various sleep disorders.

Authors:  Zuzana Lattova; Marietta Keckeis; Eszter Maurovich-Horvat; Thomas C Wetter; Johanna Wilde-Frenz; Andreas Schuld; Thomas Pollmächer
Journal:  J Psychiatr Res       Date:  2011-04-17       Impact factor: 4.791

4.  Obstructive sleep apnoea and the risk of type 2 diabetes: a meta-analysis of prospective cohort studies.

Authors:  Xia Wang; Yanping Bi; Qian Zhang; Fang Pan
Journal:  Respirology       Date:  2013-01       Impact factor: 6.424

Review 5.  On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders.

Authors:  Theresa M Buckley; Alan F Schatzberg
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

Review 6.  Practice parameters for the indications for polysomnography and related procedures: an update for 2005.

Authors:  Clete A Kushida; Michael R Littner; Timothy Morgenthaler; Cathy A Alessi; Dennis Bailey; Jack Coleman; Leah Friedman; Max Hirshkowitz; Sheldon Kapen; Milton Kramer; Teofilo Lee-Chiong; Daniel L Loube; Judith Owens; Jeffrey P Pancer; Merrill Wise
Journal:  Sleep       Date:  2005-04       Impact factor: 5.849

Review 7.  Disorders of glucose metabolism in sleep apnea.

Authors:  Naresh M Punjabi; Vsevolod Y Polotsky
Journal:  J Appl Physiol (1985)       Date:  2005-11

Review 8.  Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.

Authors:  Luciano F Drager; Sônia M Togeiro; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  J Am Coll Cardiol       Date:  2013-06-12       Impact factor: 24.094

9.  11β-hydroxysteroid dehydrogenase types 1 and 2 activity in subcutaneous adipose tissue in humans: implications in obesity and diabetes.

Authors:  Simmi Dube; Barbara J Norby; Vishwanath Pattan; Rickey E Carter; Ananda Basu; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

10.  Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: the Sleep Heart Health Study.

Authors:  Sinziana Seicean; H Lester Kirchner; Daniel J Gottlieb; Naresh M Punjabi; Helaine Resnick; Mark Sanders; Rohit Budhiraja; Mendel Singer; Susan Redline
Journal:  Diabetes Care       Date:  2008-02-11       Impact factor: 19.112

View more
  15 in total

Review 1.  Epidemiological and pathophysiological evidence supporting links between obstructive sleep apnoea and Type 2 diabetes mellitus.

Authors:  Chuen Peng Lee; Clete A Kushida; John Arputhan Abisheganaden
Journal:  Singapore Med J       Date:  2019-02       Impact factor: 1.858

Review 2.  A Review of the Associations Between Obstructive Sleep Apnea and Gestational Diabetes Mellitus and Possible Mechanisms of Disease.

Authors:  Xingyi Tong; Linzhu Yang; Chengyan Jiang; Zhiying Weng; Anju Zu; Yunjiao Hou; Yan Fang; Weimin Yang; Shibo Sun
Journal:  Reprod Sci       Date:  2022-03-07       Impact factor: 3.060

Review 3.  Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing's Syndrome.

Authors:  Lynnette K Nieman
Journal:  Endocr Rev       Date:  2022-09-26       Impact factor: 25.261

4.  Catestatin serum levels are increased in male patients with obstructive sleep apnea.

Authors:  Josip A Borovac; Zoran Dogas; Daniela Supe-Domic; Tea Galic; Josko Bozic
Journal:  Sleep Breath       Date:  2018-08-07       Impact factor: 2.816

5.  Circulating C3 and glucose metabolism abnormalities in patients with OSAHS.

Authors:  Xiaoxia Lu; Xiao Wang; Ting Xu; Yuan Feng; Yufeng Wang; Zechuan Cai; Bing Cao; Taoping Li
Journal:  Sleep Breath       Date:  2017-09-07       Impact factor: 2.816

6.  Obstructive Sleep Apnea in Gestational Diabetes: A Pilot Study of the Role of the Hypothalamic-Pituitary-Adrenal Axis.

Authors:  Margaret H Bublitz; Joao Filipe Monteiro; Andrew Caraganis; Susan Martin; Jeffrey Parker; Lucia Larson; Margaret A Miller; Ghada Bourjeily
Journal:  J Clin Sleep Med       Date:  2018-01-15       Impact factor: 4.062

7.  Adropin and Inflammation Biomarker Levels in Male Patients With Obstructive Sleep Apnea: A Link With Glucose Metabolism and Sleep Parameters.

Authors:  Josko Bozic; Josip A Borovac; Tea Galic; Tina Ticinovic Kurir; Daniela Supe-Domic; Zoran Dogas
Journal:  J Clin Sleep Med       Date:  2018-07-15       Impact factor: 4.062

8.  Health-related quality of life in type 2 diabetes mellitus patients with different risk for obstructive sleep apnea.

Authors:  Kresimir Gabric; Andrija Matetic; Marino Vilovic; Tina Ticinovic Kurir; Doris Rusic; Tea Galic; Ivana Jonjic; Josko Bozic
Journal:  Patient Prefer Adherence       Date:  2018-05-09       Impact factor: 2.711

Review 9.  The Bidirectional Relationship Between Obstructive Sleep Apnea and Metabolic Disease.

Authors:  Sarah N Framnes; Deanna M Arble
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-06       Impact factor: 5.555

10.  Impaired Glucose Metabolisms of Patients with Obstructive Sleep Apnea and Type 2 Diabetes.

Authors:  Ye Zhang; Yanpeng Xing; Haibo Yuan; Xiaokun Gang; Weiying Guo; Zhuo Li; Guixia Wang
Journal:  J Diabetes Res       Date:  2018-12-23       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.